Mount Sinai Researchers Advance a Universal Influenza Virus Vaccine

A vaccine that induces immune responses to a wide spectrum of influenza virus strains and subtypes has produced strong and durable results in early-stage clinical trials in humans, Mount Sinai researchers have found.

Go Inside the Most Innovative Minds in Science and Medicine on “Real, Smart People,” a New Podcast

Podcast from the Icahn School of Medicine at Mount Sinai offers a glimpse into the real story of how science and medicine moves forward, one smart person at a time.

Mount Sinai Researchers Bring Us One Step Closer to Universal Influenza Vaccine

A team led by researchers at the Icahn School of Medicine at Mount Sinai is getting closer to a universal flu vaccine using a novel approach they’ve developed called chimeric hemagglutinin (cHA).